Latest News
Microplastics and human health: A growing public health concern
Developed following the 19th century Industrial Revolution, plastics are synthetic or semi-synthetic polymers, categorised according to the chemical composition of their primary polymer and any side chains. These include acrylics, polyesters, silicones, polyethylenes...
Senegal joins global health initiative to strengthen healthcare systems and expand access to care
Pharmalys welcomes the news that Senegal has joined a major $12.6 billion U.S.-backed global health initiative, becoming the 26th country worldwide and the 21st in Africa to commit to this renewed effort to strengthen healthcare systems and expand access to essential...
Pharmalys completes another successful GCLP Audit at Proteome Sciences, Frankfurt, Germany
Pharmalys is proud to announce the successful completion of its most recent Good Clinical Laboratory Practice (GCLP) surveillance audit, conducted on 9-10 March 2026 at Proteome Sciences R&D GmbH & Co. KG in Frankfurt am Main, Germany. We are grateful for the...
A successful GCLP Audit at Institut Pasteur de Dakar, Senegal
Jeanette Young’s unit at Pharmalys plays a crucial role in advancing global excellence in Good Clinical Laboratory Practice (GCLP) through the delivery of highly specialised ad hoc services, including tailored GCLP trainings and comprehensive gap analyses for...
Delivering excellence under complexity: Lessons learnt from Africa
Pharmalys is an international Clinical Research Organisation (CRO) with a diverse team distributed across Europe, Asia, North America and Africa. Within our global portfolio, we support the execution of numerous clinical trials (CTs) in Africa. Across these projects,...
Jeanette Young Shares GCLP Quality Insights with the TASK Team
On Friday 13 March 2026, Jeanette Young, Laboratory Solutions & GCLP Team Lead at Pharmalys, delivered an insightful and engaging presentation at TASK HQ in South Africa. TASK is a global clinical research organisation with an in-house laboratory currently...
Quality in action: How Pharmalys drives excellence beyond the everyday
At Pharmalys, Quality is more than just a word - it is our promise. Quality can be defined as the standard of something as measured against other things of a similar kind, or the degree of excellence achieved. In clinical research, Quality ensures that clinical trials...
Ghana Leads the Way in Approving a New Fixed-Dose Deworming Treatment: A Milestone for Publish Health and Collaborative Research
Pharmalys welcomes the news that Ghana has become the first country worldwide to approve a groundbreaking fixed‑dose combination of ivermectin and albendazole - a single‑tablet treatment designed to combat soil‑transmitted helminths (STH), some of the most widespread...
A big thank you to our clients for the Client Experience Survey feedback
We would like to extend a sincere thank you to all our clients who took time out of their busy schedules to participate in the 2025 Pharmalys Client Experience Survey. We are truly grateful for the detailed feedback you provided. Your insights are invaluable and play...
Safeguarding Ethical Research While Unlocking Africa’s Potential for Clinical Innovation
The recent suspension of a proposed hepatitis B birth-dose vaccine trial in Guinea-Bissau has prompted critical reflection across the global research community. At Pharmalys, we believe this moment represents both a warning and an opportunity: a reminder that Africa...